Oskar Hansson
11 – 20 of 653
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Comparison of plasma ALZpath p-Tau217 with Lilly p-Tau217 and p-Tau181 in a neuropathological cohort
- Contribution to journal › Article
-
Mark
Predictive Value of Plasma Biomarkers in Tau-PET Transitions
- Contribution to journal › Article
-
Mark
Plasma tau biomarkers for biological staging of Alzheimer’s disease
- Contribution to journal › Article
-
Mark
Olfactory dysfunction and amyloid-positivity in Parkinson’s disease—longitudinal analysis of cognitive decline and cerebrospinal fluid markers
- Contribution to journal › Article
-
Mark
Shared and disease-specific pathways in frontotemporal dementia and Alzheimer’s and Parkinson’s diseases
- Contribution to journal › Article
-
Mark
Evidence-based standardized sample handling protocol for accurate blood-based Alzheimer's disease biomarker measurement : Results and consensus of the Global Biomarker Standardization Consortium
- Contribution to journal › Article
-
Mark
Alzheimer's disease diagnostic progression is associated with cerebrovascular disease and neuroinflammation in adults with Down syndrome
- Contribution to journal › Article
-
Mark
Alzheimer's disease outlook : controversies and future directions
- Contribution to journal › Scientific review
-
Mark
New landscape of the diagnosis of Alzheimer's disease
- Contribution to journal › Scientific review
-
Mark
Soluble cerebral Aβ protofibrils link Aβ plaque pathology to changes in CSF Aβ42/Aβ40 ratios, neurofilament light and tau in Alzheimer’s disease model mice
- Contribution to journal › Article
